KR20120005471A - 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 - Google Patents

폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Download PDF

Info

Publication number
KR20120005471A
KR20120005471A KR1020117025065A KR20117025065A KR20120005471A KR 20120005471 A KR20120005471 A KR 20120005471A KR 1020117025065 A KR1020117025065 A KR 1020117025065A KR 20117025065 A KR20117025065 A KR 20117025065A KR 20120005471 A KR20120005471 A KR 20120005471A
Authority
KR
South Korea
Prior art keywords
seq
polypeptide
kda
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020117025065A
Other languages
English (en)
Korean (ko)
Inventor
리사 엘. 헤론-올슨
드류 엠. 카트론
Original Assignee
이피토픽스, 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이피토픽스, 엘엘씨 filed Critical 이피토픽스, 엘엘씨
Publication of KR20120005471A publication Critical patent/KR20120005471A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1020117025065A 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법 Ceased KR20120005471A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21077209P 2009-03-23 2009-03-23
US61/210,772 2009-03-23

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1020157018079A Division KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167013476A Division KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Publications (1)

Publication Number Publication Date
KR20120005471A true KR20120005471A (ko) 2012-01-16

Family

ID=42781438

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020117025065A Ceased KR20120005471A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167013476A Expired - Fee Related KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020157018079A Expired - Fee Related KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020167026534A Ceased KR20160114744A (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020167013476A Expired - Fee Related KR101770321B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법
KR1020157018079A Expired - Fee Related KR101684292B1 (ko) 2009-03-23 2010-03-23 폴리펩티드 및 그람 양성 폴리펩티드를 함유하는 면역 조성물 및 사용 방법

Country Status (14)

Country Link
US (2) US9932373B2 (enExample)
EP (1) EP2411046B1 (enExample)
JP (2) JP2012521441A (enExample)
KR (4) KR20120005471A (enExample)
CN (1) CN105582524A (enExample)
AR (1) AR075933A1 (enExample)
AU (1) AU2016201992B2 (enExample)
BR (1) BRPI1011856A2 (enExample)
CA (1) CA2756313A1 (enExample)
IL (2) IL215330A (enExample)
MX (1) MX339461B (enExample)
NZ (2) NZ595231A (enExample)
WO (1) WO2010111273A1 (enExample)
ZA (1) ZA201106959B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101119744B (zh) 2005-02-14 2013-03-13 埃皮托皮克斯有限责任公司 来自金黄色葡萄球菌的多肽和使用方法
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso
AU2013202253B2 (en) * 2009-04-14 2015-03-19 Novartis Ag Compositions for immunising against Staphylococcus aureus
US9724658B2 (en) * 2011-03-28 2017-08-08 Fast & Fluid Management B.V. Method of homogenizing a liquid
US8753643B1 (en) 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use
US20170023569A1 (en) * 2014-01-10 2017-01-26 University Of Rochester Diagnostic device and method for detection of staphylococcus infection
WO2017011340A2 (en) * 2015-07-10 2017-01-19 Epitopix, Llc. Proteins and immunizing compositions containing klebsiella proteins and methods of use
US11324815B2 (en) 2016-10-21 2022-05-10 Socpra—Sciences et Genie, S.E.C. Vaccine constructs and uses thereof against Staphylococcus infections

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981685A (en) 1986-03-07 1991-01-01 Utah State University Foundation Bacterial extract vaccines for veterinary application
US5554372A (en) 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US5292869A (en) 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US5830479A (en) 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
ES2279511T3 (es) 1994-02-09 2007-08-16 Epitopix Llc Inmunizacion activa utilizando una proteina receptor de sideroforo.
US5538733A (en) 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US6403337B1 (en) 1996-01-05 2002-06-11 Human Genome Sciences, Inc. Staphylococcus aureus genes and polypeptides
AU3126097A (en) 1996-05-16 1997-12-05 The Texas A & M University System Collagen binding protein compositions and methods of use
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
US20020061569A1 (en) * 2000-03-21 2002-05-23 Robert Haselbeck Identification of essential genes in prokaryotes
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
BR0206293B1 (pt) 2001-01-03 2015-01-20 Epitopix Llc “composições compreendendo polipeptídeos receptores de sideróforos e porinas de micróbio gram-negativo, bem como métodos de isolar polipeptídeos de membrana externa
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
GB0107661D0 (en) * 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
EP2339344A1 (en) 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
WO2003020875A2 (en) 2001-06-17 2003-03-13 D-Squared Biotechnologies, Inc. Staphylococci surface-exposed immunogenic polypeptides
US6720160B2 (en) 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
AU2003254555A1 (en) 2002-07-26 2004-02-23 Intercell Ag S. aureus antigene
BRPI0414267A (pt) 2003-09-19 2006-11-21 Epitopix Llc polipeptìdeos de campilobacter e métodos de uso
EP1740604A2 (en) 2004-04-27 2007-01-10 Intercell AG Td antigens
CA2576247C (en) 2004-08-26 2016-08-30 The University Of Western Ontario Pharmaceutical compositions comprising inhibitors of iron transport, and method of identifying iron transport inhibitors, in staphylococcus aureus
KR20070085457A (ko) * 2004-10-25 2007-08-27 더 유니버시티 오브 웨스턴 온타리오 스태필로코쿠스 아우레우스의 철에 의해 조절되는 표면결정인자 ＩｓｄＡ, ＩｓｄＢ, 및 ＩｓｄＣ 기재 백신,조성물 및 방법
CN101119744B (zh) 2005-02-14 2013-03-13 埃皮托皮克斯有限责任公司 来自金黄色葡萄球菌的多肽和使用方法
US8021885B2 (en) 2006-10-11 2011-09-20 Evonik Rohmax Additives Gmbh Method for the determination of the oxidative stability of a lubricating fluid
BRPI1011856A2 (pt) 2009-03-23 2020-11-03 Epitopix, Llc polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso

Also Published As

Publication number Publication date
KR101770321B1 (ko) 2017-09-05
AU2010229498A1 (en) 2011-10-13
CN105582524A (zh) 2016-05-18
EP2411046A4 (en) 2012-09-19
KR101684292B1 (ko) 2016-12-08
IL215330A0 (en) 2011-12-29
MX339461B (es) 2016-05-27
WO2010111273A1 (en) 2010-09-30
US9932373B2 (en) 2018-04-03
JP6092933B2 (ja) 2017-03-08
CN102448489A (zh) 2012-05-09
NZ595231A (en) 2014-03-28
US20120034258A1 (en) 2012-02-09
JP2015164949A (ja) 2015-09-17
EP2411046B1 (en) 2017-12-06
AR075933A1 (es) 2011-05-04
IL215330A (en) 2016-12-29
ZA201106959B (en) 2012-06-27
IL248523A0 (en) 2016-12-29
EP2411046A1 (en) 2012-02-01
NZ614557A (en) 2015-03-27
US20180237481A1 (en) 2018-08-23
KR20150093774A (ko) 2015-08-18
MX2011009949A (es) 2011-10-06
JP2012521441A (ja) 2012-09-13
AU2016201992A1 (en) 2016-04-21
CA2756313A1 (en) 2010-09-30
BRPI1011856A2 (pt) 2020-11-03
AU2016201992B2 (en) 2018-02-15
KR20160064237A (ko) 2016-06-07
KR20160114744A (ko) 2016-10-05

Similar Documents

Publication Publication Date Title
US9981028B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2016201992B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
AU2010229498B2 (en) Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
CN102448489B (zh) 多肽和含有革兰氏阳性多肽的免疫组合物及使用方法
AU2015258239B2 (en) Polypeptides from staphylococcus aureus and methods of use
AU2012244060A1 (en) Polypeptides from staphylococcus aureus and methods of use

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20111024

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130718

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20150206

Patent event code: PE09021S01D

A107 Divisional application of patent
AMND Amendment
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20150706

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20151127

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20150206

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20151127

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20150706

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20130718

Comment text: Amendment to Specification, etc.

PX0601 Decision of rejection after re-examination

Comment text: Decision to Refuse Application

Patent event code: PX06014S01D

Patent event date: 20160328

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20160226

Comment text: Decision to Refuse Application

Patent event code: PX06011S01I

Patent event date: 20151127

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20150706

Comment text: Notification of reason for refusal

Patent event code: PX06013S01I

Patent event date: 20150206

Comment text: Amendment to Specification, etc.

Patent event code: PX06012R01I

Patent event date: 20130718

A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20160520